Skip to main content

Advertisement

SpringerLink
Log in

Management of myocardial infarction in immune thrombocytopenic purpura with anti-phospholipid antibodies

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Sometimes it is difficult to distinguish anti-phospholipid syndrome (APS) from immune thrombocytopenic purpura (ITP). Here we present successful management of ITP with anti-phospholipid antibodies, complicated by acute coronary syndrome (ACS), using CT coronary angiography (CTCA). The therapy for ITP may be changed for APS if ACS was thromboembolic event. As coronary angiography is thought to be very dangerous for patients with severe thrombocytopenia, noninvasive CTCA was desirable for our patient. Since no occlusion or narrowing was observed in CTCA, she has been safely treated as ITP with immunosuppressive agents throughout the course without antiplatelet or antithrombin therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. O’Connor RE, Brady W, Brooks SC, Diercks D, Egan J, Ghaemmaghami C, Menon V, O’Neil BJ, Travers AH, Yannopoulos D (2010) Part 10: acute coronary syndromes: 2010 American heart association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 122:S787–S817

    Article  PubMed  Google Scholar 

  2. Cervera R, Tektonidou MG, Espinosa G, Cabral AR, González EB, Erkan D, Vadya S, Adrogué HE, Solomon M, Zandman-Goddard G, Shoenfeld Y (2011) Task force on catastrophic antiphospholipid syndrome (APS) and non-criteria APS manifestations (II): thrombocytopenia and skin manifestations. Lupus 20:174–181

    Article  PubMed  CAS  Google Scholar 

  3. Harris EN, Gharavi AE, Hegde U, Derue G, Morgan SH, Englert H, Chan JK, Asherson RA, Hughes GR (1985) Anticardiolipin antibodies in autoimmune thrombocytopenic purpura. Br J Haematol 59:231–234

    Article  PubMed  CAS  Google Scholar 

  4. Stasi R, Stipa E, Masi M, Oliva F, Sciarra A, Perrotti A, Olivieri M, Zaccari G, Gandolfo GM, Galli M et al (1994) Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura. Blood 84:4203–4208

    PubMed  CAS  Google Scholar 

  5. Funauchi M, Hamada K, Enomoto H, Ikoma S, Ohno M, Kinoshita K, Horiuchi A (1997) Characteristics of the clinical findings in patients with idiopathic thrombocytopenic purpura who are positive for anti-phospholipid antibodies. Intern Med 36:882–885

    Article  PubMed  CAS  Google Scholar 

  6. Bidot CJ, Jy W, Horstman LL, Ahn ER, Jimenez JJ, Yaniz M, Lander G, Ahn YS (2005) Antiphospholipid antibodies in immune thrombocytopenic purpura tend to emerge in exacerbation and decline in remission. Br J Haematol 128:366–372

    Article  PubMed  CAS  Google Scholar 

  7. Pierrot-Deseilligny Despujol C, Michel M, Khellaf M, Gouault M, Intrator L, Bierling P, Godeau B (2008) Antiphospholipid antibodies in adults with immune thrombocytopenic purpura. Br J Haematol 142:638–643

    Article  PubMed  Google Scholar 

  8. Diz-Küçükkaya R, Hacihanefioğlu A, Yenerel M, Turgut M, Keskin H, Nalçaci M, Inanç M (2001) Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study. Blood 98:1760–1764

    Article  PubMed  Google Scholar 

  9. Galli M, Luciani D, Bertolini G, Barbui T (2003) Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 101:1827–1832

    Article  PubMed  CAS  Google Scholar 

  10. Galli M, Luciani D, Bertolini G, Barbui T (2003) Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood 102:2717–2723

    Article  PubMed  CAS  Google Scholar 

  11. Horstman LL, Jy W, Bidot CJ, Ahn YS, Kelley RE, Zivadinov R, Maghzi AH, Etemadifar M, Mousavi SA, Minagar A (2009) Antiphospholipid antibodies: paradigm in transition. J Neuroinflamm 6:3

    Article  Google Scholar 

  12. Fuchi T, Kondo T, Sase K, Takahashi M (1999) Primary percutaneous transluminal coronary angioplasty performed for acute myocardial infarction in a patient with idiopathic thrombocytopenic purpura. Jpn Circ J 63:133–136

    Article  PubMed  CAS  Google Scholar 

  13. Kim JH, Park KU, Chun WJ, Kim SH, Nay DY (2006) Primary percutaneous coronary intervention for acute myocardial infarction with idiopathic thrombocytopenic purpura: a case report. J Korean Med Sci 21:355–357

    Article  PubMed  Google Scholar 

  14. Gracia MC, Cebollero IC, Lezcano JS, Osuna GG, Miguel JA, Peralta LP (2008) Invasive treatment performed for acute myocardial infarction in a patient with immune thrombocytopenic purpura. Int J Cardiol 127:e183–e185

    Article  PubMed  Google Scholar 

  15. Yildiz A, Coskun U, Batukan OE, Keskin K (2010) Primary percutaneous coronary intervention for acute myocardial infarction in a young female with idiopathic thrombocytopenic purpura: a case report and review. Case Rep Med 2010:854682

    Google Scholar 

  16. Neskovic AN, Stankovic I, Milicevic P, Aleksic A, Vlahovic-Stipac A, Calija B, Putnikovic B (2010) Primary PCI for acute myocardial infarction in a patient with idiopathic thrombocytopenic purpura. A case report and review of the literature. Herz 35:43–49

    Article  PubMed  Google Scholar 

  17. Sarpatwari A, Bennett D, Logie JW, Shukla A, Beach KJ, Newland AC, Sanderson S, Provan D (2010) Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom general practice research database. Haematologica 95:1167–1175

    Article  PubMed  Google Scholar 

  18. Enger C, Bennett D, Forssen U, Fogarty PF, McAfee AT (2010) Comorbidities in patients with persistent or chronic immune thrombocytopenia. Int J Hematol 92:289–295

    Article  PubMed  Google Scholar 

  19. Marie I, Maurey G, Hervé F, Hellot MF, Levesque H (2006) Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature. Br J Dermatol 155:714–721

    Article  PubMed  CAS  Google Scholar 

  20. Caress JB, Cartwright MS, Donofrio PD, Peacock JE Jr (2003) The clinical features of 16 cases of stroke associated with administration of IVIg. Neurology 60:1822–1824

    Article  PubMed  CAS  Google Scholar 

  21. Al-Riyami AZ, Lee J, Connolly M, Shereck E (2011) Cerebral sinus thrombosis following IV immunoglobulin therapy of immune thrombocytopenia purpura. Pediatr Blood Cancer 57:157–159

    Article  PubMed  Google Scholar 

  22. Arfors L, Winiarski J, Lefvert AK (1996) Prevalence of antibodies to cardiolipin in chronic ITP and reactivity with platelet membranes. Eur J Haematol 56:230–234

    Article  PubMed  CAS  Google Scholar 

  23. Lipp E, von Felten A, Sax H, Müller D, Berchtold P (1998) Antibodies against platelet glycoproteins and antiphospholipid antibodies in autoimmune thrombocytopenia. Eur J Haematol 60:283–288

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The Authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Hyogo Prefectural Tsukaguchi Hospital, 6-8-17 Minamitsukaguchi, Amagasaki, Hyogo, 661-0012, Japan

    Rie Tabata & Yoshio Kita

  2. Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan

    Chiharu Tabata

Authors
  1. Rie Tabata
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chiharu Tabata
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yoshio Kita
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rie Tabata.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tabata, R., Tabata, C. & Kita, Y. Management of myocardial infarction in immune thrombocytopenic purpura with anti-phospholipid antibodies. J Thromb Thrombolysis 35, 115–118 (2013). https://doi.org/10.1007/s11239-012-0763-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-012-0763-1

Keywords

Search

Navigation